Two Sigma Advisers’s Zimmer Biomet ZBH Stock Holding History

Two Sigma Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-5,150	Closed	-$375K	–	2456
2013 Q2	$375K	Buy	+5,150	New	+$385K	0.01%	1549

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Two Sigma Advisers's ZBH Position: Q3 2025 in Review

Two Sigma Advisers sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 35,700 shares — an estimated $3.26M sold.

Two Sigma Advisers first reported a position in ZBH in Q4 2013 and held it in 37 quarters. The position peaked at $189M in Q2 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Two Sigma Advisers reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Two Sigma Advisers sold 35,700 Zimmer Biomet shares in Q3 2025, an estimated $3.26M.
Two Sigma Advisers first reported a position in Zimmer Biomet in Q4 2013 and held it in 37 quarters.
Two Sigma Advisers's Zimmer Biomet position peaked at $189M in Q2 2021.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.